alexa Multidrug Resistant Bacterial Pathogens: The Need For Action
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Marcelo E Tolmasky
Keynote: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.005
Abstract
There is currently an epidemic of antibiotic resistant bacterial infections that has been identified as one of the greatest threats to human health. Within this epidemic, a group of pathogens responsible for most deaths in hospital infections has been individualized and named ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter). Numerous strains resistant to most antibiotics, including aminogylcosides and carbapenems, are becoming increasingly hard to treat. The major need for new antibiotic therapies is for severe infections caused by multidrug resistant Gram-negatives. The resistance to aminoglycosides is mainly caused by enzymatic modification. The aminoglycoside 6?-N-acetyltransferase type Ib [AAC(6?)-Ib] is one of the most clinically relevant resistance enzymes and it was found in isolates of all four Gram-negatives included in the ESKAPE group. We have characterized mechanisms of dissemination of aac(6?)-Ib at the molecular and cellular level and explored strategies to counter the resistance conferred by AAC(6?)-Ib. We identified a locked nucleic acid/oligodeoxynucleotide hybrid oligomer that reduced the levels of resistance to amikacin by eliciting RNase P-mediated degradation of the mRNA. Furthermore, using in silico molecular docking and other screening methods we identified inhibitors of the AAC(6?)-Ib enzymatic activity. One of them, Zn2+ in complex with the ionophore pyrithione was able to reverse resistance to amikacin of aac(6?)-Ib-harboring Gram-negatives in culture. Our results indicate that inhibition of expression of aminoglycoside modifying enzymes or inhibition of their activity could contribute to alleviate the current antibiotic resistance crisis.
Biography
Marcelo E Tolmasky has completed his PhD at University of Buenos Aires and did his Postdoctoral studies at the Oregon Health & Sciences University. He is currently a Professor at California State University Fullerton and is the Director of the Center for Applied Biotechnology studies. He has published over 85 papers in peer-reviewed journals and co-edited the book ?Enzyme-Mediated Resistance to Antibiotics?. Among other awards he received are the Biotechnology Research Faculty Award 2002 (CSUPERB) and the Outstanding Professor CSUF (the highest honor the university confers) 2009-2010.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords